RECURRENT EPENDYMAL TUMOR

Clinical trials for RECURRENT EPENDYMAL TUMOR explained in plain language.

Never miss a new study

Get alerted when new RECURRENT EPENDYMAL TUMOR trials appear

Sign up with your email to follow new studies for RECURRENT EPENDYMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted drug trial offers hope for kids with Tough-to-Treat cancers

Disease control Ongoing

This study is testing an oral drug called ulixertinib in children and adolescents whose advanced cancers have not responded to standard treatments and have a specific genetic change in a cell pathway called MAPK. The main goal is to see if the drug can shrink tumors and control t…

Matched conditions: RECURRENT EPENDYMAL TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

RECURRENT EPENDYMAL TUMOR

Get alerted when new RECURRENT EPENDYMAL TUMOR trials appear

Targeted drug trial offers hope for kids with Tough-to-Treat cancers